Cargando…
JAK3-STAT pathway blocking benefits in experimental lupus nephritis
BACKGROUND: Lupus nephritis (LN) is a complex chronic autoimmune disease of unknown etiology characterized by loss of tolerance against several self-antigens. Cytokines are known to be central players in LN pathogenesis. The Janus kinase-signal transducer and activator of transcription (JAK-STAT) pa...
Autores principales: | Ripoll, Èlia, de Ramon, Laura, Draibe Bordignon, Juliana, Merino, Ana, Bolaños, Nuria, Goma, Montse, Cruzado, Josep M., Grinyó, Josep M., Torras, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898357/ https://www.ncbi.nlm.nih.gov/pubmed/27278657 http://dx.doi.org/10.1186/s13075-016-1034-x |
Ejemplares similares
-
Erratum to: JAK3-STAT pathway blocking benefits in experimental lupus nephritis
por: Ripoll, Èlia, et al.
Publicado: (2016) -
CD40 Gene Silencing Reduces the Progression of Experimental Lupus Nephritis Modulating Local Milieu and Systemic Mechanisms
por: Ripoll, Èlia, et al.
Publicado: (2013) -
Correction: CD40 Gene Silencing Reduces the Progression of Experimental Lupus Nephritis Modulating Local Milieu and Systemic Mechanisms
por: Ripoll, Èlia, et al.
Publicado: (2013) -
The gene silencing of IRF5 and BLYSS effectively modulates the outcome of experimental lupus nephritis
por: Guiteras, Jordi, et al.
Publicado: (2021) -
Dual Costimulatory and Coinhibitory Targeting with a Hybrid Fusion Protein as an Immunomodulatory Therapy in Lupus Nephritis Mice Models
por: Guiteras, Jordi, et al.
Publicado: (2022)